The Gut-Immune System and Hormones Role in Overall Wellness

Dive into the world of the gut-immune system and hormones and their crucial role in supporting immune health and overall wellness.

Abstract

I wrote this educational post to share how I moved from medication stacks to a systems-biology model that begins in the gut and extends through the immune, endocrine, and nervous systems. Drawing on modern methods such as metagenomic sequencing, metabolomics, intestinal permeability assays, and autonomic measures (e.g., HRV), I explain how dysbiosis, leaky gut, and LPS-driven inflammation disrupt estrogen metabolism, thyroid hormone conversion, insulin sensitivity, and mood. You will learn why supporting the estrobolome, optimizing vitamin D3–K2–A cofactors, and balancing iodine–selenium for thyroid are pivotal. I discuss practical protocols using diet, prebiotics, probiotics, butyrate support, DIM/I3C, calcium D-glucarate, glutamine, methylation cofactors, and, when appropriate, shilajit to sustain free testosterone. I also show where integrative chiropractic care fits: improving vagal tone, diaphragmatic mechanics, and autonomic balance to normalize motility, lower inflammation, and help good plans work. Throughout, I reference my clinical observations from ChiroMed and the latest findings from leading researchers, so you can see the rationale behind each step and apply this roadmap safely and effectively.

Why I Now Start With The Gut, Then Layer Hormones, Thyroid, And Structure

I trained in conventional models and spent years optimizing hormones and metabolism. I prescribed intensively, studied incretins and GLP-1, and did everything I could to improve diabetes and endocrine care. Many patients improved—but too many plateaued. The turning point came when I consistently addressed gut integrity and the neuroimmune axis first: patients’ medication burdens decreased, weight and energy normalized, and mood and cycles stabilized. When I dug deeper into the 25–30% who still struggled, I found a common thread: dysbiosis, intestinal permeability, and autonomic dysregulation blocked progress.
My clinical lesson: persistent symptoms usually reflect a convergence of microbiome imbalance, barrier dysfunction, immune activation, autonomic imbalance, and environmental mismatch. These systems converge in the gut. That’s why my care integrates functional nutrition, targeted supplementation, hormone and thyroid optimization, and integrative chiropractic to restore nervous system balance and biomechanics. Across my clinical work at ChiroMed and case reflections I share on LinkedIn, a gut-first framework reliably transforms outcomes (Jimenez, n.d.-a; Jimenez, n.d.-b).

The Gut Microbiome As A Neuroendocrine And Immune Control Center

The microbiome is a living organ system. In a healthy state, it:

• Produces short-chain fatty acids (SCFAs)—especially butyrate, propionate, and acetate—that fuel colonocytes, tighten epithelial tight junctions, and tame inflammation (Canfora et al., 2019).
• Trains GALT and regulatory T cells (Tregs), fostering immune tolerance (Turnbaugh & Gordon, 2019).
• Maintains barrier integrity, preventing lipopolysaccharide (LPS) translocation and downstream TLR4–NF-κB signaling (Camilleri, 2019).
• Modulates neurotransmitters and the HPA axis, influencing serotonin via enterochromaffin cells and stress resilience (Cryan & Dinan, 2015).
• Shapes hormone metabolism, including the estrobolome, insulin sensitivity, and thyroid conversion.

When dysbiosis develops, we see reduced butyrate-producing bacteria, an excess of pathobionts, and elevated beta-glucuronidase—an enzyme that can deconjugate estrogens and promote estrogen recirculation. Clinically, this presents as bloating, irregular stools, acne, brain fog, fatigue, weight plateaus, and hormone therapy that “doesn’t stick.” Mechanistically, increased LPS fuels systemic inflammation and insulin resistance; reduced SCFAs loosen junctions and weaken mucosal defense; and neuroendocrine signaling drifts toward anxiety, low mood, and poor sleep.

Intestinal Permeability, Zonulin, and the Inflammation–Endocrine Loop

“Leaky gut” is a measurable phenomenon. Tight junctions—regulated by proteins like claudin, occludin, and zonulin—hold epithelial cells together. When zonulin rises in response to gluten, infections, dysbiosis, or stress, the junctions loosen, allowing dietary antigens and microbial fragments to enter the circulation (Fasano, 2012). The consequences:

• Immune activation: Elevated TNF-α and IL-6 amplify systemic inflammation.
• Endocrine disruption: Cytokines increase cortisol and insulin, blunt T4→T3 conversion, and alter sex hormone balance.
• Metabolic effects: Raised insulin and cortisol promote fat storage and alter appetite circuits.

Repeated postprandial endotoxemia (LPS spikes after meals) is well documented with high-fat, ultra-processed diets, fueling insulin resistance and barrier erosion (Cani et al., 2007). In my practice, I routinely see elevated zonulin, LPS-binding protein, low SCFAs, and high beta-glucuronidase in stressed, symptomatic patients. When we seal the barrier and calm LPS, endocrine therapies begin to work the way we expect.

The Estrobolome, Beta-Glucuronidase, And Estrogen Recirculation

The estrobolome—the gut microbial genes that metabolize estrogens—determines whether estrogens are excreted or recirculated. In the liver, estrogens are conjugated (often glucuronidated) and excreted via bile. If the microbiome produces excess beta-glucuronidase, it deconjugates estrogens in the intestine, thereby enabling reabsorption through the intestinal wall (Plottel & Blaser, 2011; Flores et al., 2012). Add constipation, and you compound recirculation. Clinically, I see:

• Worsened PMS, mastalgia, fibrocystic changes, and heavier cycles.
• Frustration with hormone therapy due to increased metabolites returning to circulation.
• Mood variability and breast density changes when the 2-OH:16-OH balance is unfavorable.

Supporting fiber, calcium D-glucarate, DIM/I3C, methylation cofactors, bile flow, and daily bowel movements can reverse this loop.

PCOS, Endometriosis, And The Gut–Hormone Axis

• PCOS: Dysbiosis raises LPS and zonulin, driving inflammation and insulin resistance, which increases ovarian theca cell androgen production. Result: hyperandrogenism, anovulation, acne, and metabolic risk (Qi et al., 2022). When I rebuild the barrier, raise SCFAs, and add resistance training with targeted nutrition, fasting insulin drops, cycles stabilize, and skin clears.
• Endometriosis: Elevated beta-glucuronidase and permeability raise circulating estrogen and pelvic inflammation. Estrogen metabolism favors 2-hydroxylation over proliferative or genotoxic pathways when supported with DIM, I3C, methylation, and glucuronidation aids (Yager & Davidson, 2006; Taylor et al., 2020). My patients often report lighter cycles and reduced pain when transit improves, and recirculation decreases.

Thyroid Conversion, Iodine–Selenium Synergy, and Hashimoto’s

Thyroid function hinges on substrate availability and redox safety:

• Iodine is essential for T4/T3 synthesis, but it must be managed carefully—especially in autoimmune thyroiditis.
• Selenium-dependent enzymes (glutathione peroxidases, deiodinases) detoxify H2O2 used by TPO and convert T4 to T3. Low selenium levels increase oxidative stress and can heighten antibody activity; supplementation can lower TPO antibody levels in some patients (Gärtner et al., 2002).

In Hashimoto’s, dysbiosis and intestinal permeability elevate cytokine levels, impairing T4→T3 conversion and nutrient absorption (Caturegli et al., 2014). Correcting the microbiome, supporting the barrier, and using vitamin D3–K2–A with magnesium (for vitamin D metabolism) improves immune tolerance and thyroid status. In my clinic, combining selenium (100–200 mcg/day) with gut repair and stress modulation often stabilizes symptoms and antibody trends.

Vitamin D3, K2, Magnesium, And Vitamin A: Directing Calcium And Calming Immunity

Many patients take vitamin D3 without cofactors. For safety and efficacy:

• Magnesium supports the enzymes that convert D into its active forms.
• Vitamin K2 (MK-7) activates osteocalcin and matrix Gla protein (MGP), directing calcium to bones and away from arteries (Beulens et al., 2013).
• Vitamin A (retinol) works synergistically with D and K to balance bone remodeling and epithelial integrity.

I generally target 25(OH)D at 50–70 ng/mL, titrating based on labs, with D3 taken with fat and magnesium, plus K2 (and judicious vitamin A when indicated) (Pilz et al., 2019; Mitchell et al., 2022). Clinically, this reduces musculoskeletal aches, improves mood and immune balance, and safeguards vascular health during endocrine optimization.

Akkermansia, SCFAs, And Metabolic Flexibility

I pay close attention to Akkermansia muciniphila, a mucin-degrading bacterium associated with stronger mucus layers and better metabolic profiles. Low levels of Akkermansia correlate with barrier fragility and weight-loss resistance (Everard & Cani, 2013). When I support mucosal nutrition (polyphenols from berries and pomegranates; prebiotic fibers; omega-3s), Akkermansia often rebounds. When combined with fiber-induced SCFAs, patients regain insulin sensitivity, see improved fasting glucose, and break stubborn weight plateaus.

Evidence-Based Tools That Inform Personalization

Modern research methods help move from guesswork to precision:

• Metagenomics identifies microbial composition and functional genes (e.g., SCFA producers, Enterobacteriaceae) to target interventions (Turnbaugh & Gordon, 2019).
• Metabolomics measures functional outputs—such as SCFAs, bile acids, and indoles—to gauge progress.
• Permeability assays (e.g., serum zonulin, lactulose/mannitol) and markers like LPS-binding protein quantify barrier function (Camilleri, 2019).
• Neurogastroenterology and HRV assessments tailor autonomic and motility interventions (Tracey, 2002).

This data-driven approach, combined with clinical observation, improves accuracy, safety, and recovery speed.

Integrative Chiropractic Care: Why Structure And Autonomics Matter

As a chiropractor and nurse practitioner, I witness how biomechanics and the autonomic nervous system shape gut and endocrine function:

• Vagal tone: Gentle cervical work, rib mechanics, diaphragmatic release, and paced breathing increase parasympathetic output, improving gastric accommodation and GI motility, while reducing visceral hypersensitivity.
• Spinal and pelvic mechanics: Thoracolumbar and sacral segments modulate sympathetic and parasympathetic outflow to the GI tract; restoring mobility reduces nociceptive drive and systemic cytokine levels.
• Movement prescriptions: Rhythmic aerobic work and resistance training improve insulin sensitivity and myokine profiles, enhancing metabolic resilience.

In my practice, adding HRV-guided breathing, diaphragmatic training, and targeted adjustments accelerates gut recovery and stabilizes mood and sleep. Structural integration is not optional; it is central to steady autonomic balance and endocrine stability (Tracey, 2002; Cryan & Dinan, 2015; Jimenez, n.d.-a; Jimenez, n.d.-b).

DIM, I3C, And Safer Estrogen Metabolism

Diindolylmethane (DIM) and indole-3-carbinol (I3C) help steer estrogen toward the 2-hydroxy (2-OH) pathway, away from 4-OH quinone-prone and 16-OH proliferative metabolites. Mechanisms include modulation of CYP enzymes and support of COMT-mediated methylation (Bradlow, 2019; Kabat et al., 2006). In practice:

• Women: DIM 100–150 mg/day, titrating up to 300 mg/day when PMS, mastalgia, or estrogen dominance persists.
• Men: DIM 300 mg/day, up to 600 mg/day in select prostate risk scenarios while monitoring.

I pair DIM with methylated B vitamins and sulforaphane (Nrf2 activation) to ensure conjugation and detox pathways keep pace (Singh et al., 2011). Clinically, patients report improved breast density profiles and better tolerance to HRT when DIM is maintained.

Calcium D-Glucarate, Methylation, Bile Flow, And Daily Excretion

To reduce beta-glucuronidase reactivation and enterohepatic recirculation, I use:

• Calcium D-glucarate to support glucuronidation.
• Methylation support (methylfolate, methylcobalamin, B6/P5P, TMG) to detoxify catechol estrogens and maintain COMT function—especially when 4-OH is elevated.
• Bile flow support with bitters (e.g., gentian, dandelion) and hydration to carry conjugated estrogens into the intestine.
• Transit optimization with fiber and gentle movement. Constipation is a nonstarter—daily bowel movements are mandatory for estrogen safety.

This Phase I–II–III strategy ensures metabolites are formed safely (Phase I), conjugated (Phase II), and eliminated (Phase III).

Glutamine, Zinc Carnosine, And Mucosal Repair

When permeability is high or mucosal stress is severe, I deploy:

• L-glutamine to fuel enterocytes and bolster tight junction protein expression.
• Zinc carnosine to stabilize mucosal surfaces and reduce oxidative stress (Ueda et al., 2007).
• Omega-3s and demulcents as needed.

Patients often experience reduced bloating, better stool quality, and calmer skin when mucosal repair is prioritized.

Shilajit And Free Testosterone: Sustaining Benefits Across Pellet Cycles

Late in testosterone pellet cycles, many patients report symptom drift despite acceptable total testosterone. The culprit is often a decline in free testosterone, the bioavailable fraction that drives receptor signaling. Purified shilajit has shown significant increases in both total and free testosterone (e.g., ~31% and ~51% respectively at 250 mg twice daily in a randomized, placebo-controlled trial), likely via fulvic acid–mediated mitochondrial and transport effects (Pandit et al., 2016). In my clinic:
Adding purified shilajit during the latter half of a pellet cycle stabilizes free testosterone without pushing total levels into side-effect territory.
Patients report steadier energy, drive, and recovery.
I integrate shilajit into a comprehensive HRT support stack (DIM, methylated B’s, sulforaphane, CoQ10) to support balanced metabolism and oxidative protection.
For women with PCOS or androgen sensitivity, I avoid raising androgens and instead emphasize estrogen detoxification and an insulin-sensitizing lifestyle.

Practical, Stepwise Clinical Plan

Here is how I typically structure care:

• Phase 1: Calm the fire
  • Remove ultra-processed foods, dyes, and excess alcohol.
  • Establish hydration, protein adequacy, and high-fiber, polyphenol-rich meals.
  • Start multi-strain probiotics, prebiotics (inulin, FOS, GOS, resistant starch), and L-glutamine; add zinc carnosine if mucosal stress is evident.
  • Begin paced breathing (≈6 breaths/min), humming or gargling, and chiropractic sessions to downshift sympathetic tone.
  • Target sleep: a consistent schedule, a cool, dark room, and morning light.
• Phase 2: Restore and rebalance
  • Add DIM/I3C based on symptoms or metabolite data; support methylation (methylfolate, B12, B6, TMG).
  • Introduce calcium D-glucarate for glucuronidation; enhance transit with diverse fibers.
  • Train with progressive resistance (3x/week) and zone 2 cardio (2x/week).
  • Ensure daily bowel movements and support bile flow with bitters.
• Phase 3: Optimize and personalize
  • Reassess stool metrics (zonulin, SCFAs, beta-glucuronidase, Akkermansia) and hormone metabolites.
  • Correct nutrient deficits (vitamin D, magnesium, omega-3s, iron, zinc).
  • Support Akkermansia with polyphenols and mucin-feeding fibers; maintain D3–K2–A for calcium handling and immune balance.
  • For pellet-based HRT, consider shilajit to sustain free testosterone; for PCOS or estrogen dominance, lean on detox supports without increasing androgens.
  • Maintain integrative chiropractic care to reinforce autonomic balance and movement quality.

Modulating Women’s Hormones- Video

Clinical Observations From My Practice

From my work at ChiroMed and professional updates I share on LinkedIn:

• Patients with “great labs” but persistent symptoms often harbor dysbiosis, increased permeability, or elevated beta-glucuronidase—addressing these unlocks progress (Jimenez, n.d.-a; Jimenez, n.d.-b).
• Pairing resistance training with gut repair stabilizes cycles and insulin in PCOS; skin and mood follow.
• Akkermansia repletion tracks with breaking weight-loss plateaus, even after GLP-1 use.
• Integrative chiropractic care improves adherence and resilience—when pain and sleep improve, nutrition and movement protocols stick, accelerating gut and hormone balance.

Why These Techniques Work: Physiology-First Reasoning

• Prebiotics and fiber → raise SCFAs, especially butyrate, tightening junctions and lowering inflammatory signaling (Canfora et al., 2019). This reduces LPS leakage and stabilizes endocrine pathways.
• Synbiotics (probiotics + prebiotics) → re-seed commensals and feed them, improving stool form, immune markers, and motility in IBS and dysbiosis.
• Glutamine and zinc carnosine → restore epithelial energy and mucosal structure, lowering antigen translocation (Ueda et al., 2007).
• DIM/I3C → steer estrogen toward 2-OH and away from 4-OH/16-OH, lowering quinone burden and proliferative signaling (Bradlow, 2019; Kabat et al., 2006).
• Methylation support → completes detox of catechol estrogens and protects DNA via COMT and related pathways.
• Calcium D-glucarate → promotes glucuronidation and reduces beta-glucuronidase-driven recirculation.
• D3–K2–A with magnesium → improves immune modulation and calcium trafficking, protecting bone and vasculature (Beulens et al., 2013; Pilz et al., 2019; Mitchell et al., 2022).
• Iodine with selenium → restores thyroid hormone synthesis while protecting against H2O2-driven oxidative damage; supports deiodinases (Gärtner et al., 2002; Zimmermann, 2003).
• Shilajit → raises free testosterone and supports mitochondrial function, smoothing symptom curves across pellet cycles (Pandit et al., 2016).
• Chiropractic-informed autonomic care → increases vagal tone and reduces nociception, lowering cytokines and improving motility, digestion, and sleep (Tracey, 2002; Cryan & Dinan, 2015).

Putting It All Together: A Gut-First, Whole-Person Strategy

When we respect the body’s systems biology, we see why a gut-first strategy with autonomic balance makes hormones and thyroid therapies work predictably. By:

• Sealing the barrier and raising SCFAs,
• Lowering LPS and cytokines,
• Steering estrogen metabolism toward safer pathways with DIM/I3C and ensuring excretion with calcium D-glucarate, fiber, and bile flow,
• Optimizing vitamin D3–K2–A with magnesium and carefully integrating iodine–selenium for thyroid,
• Supporting bioavailable androgens with shilajit when appropriate,
• And integrating chiropractic care to normalize autonomic tone and movement.

We consistently move patients from symptom management to durable health. This approach is practical, measurable, and aligned with modern, evidence-based methods. In my experience, it is also the fastest, safest way to feel well and stay well.

References

• Microbiome and human health: from basic science to clinical applications (Turnbaugh, P. J., & Gordon, J. I., 2019). Nature Medicine.
• Short-chain fatty acids and human health (Canfora, E. E., Wopereis, S., & Blaak, E. E., 2019). Trends in Endocrinology & Metabolism.
• Gut barrier function and the microbiome (Camilleri, M., 2019). Nature Reviews Gastroenterology & Hepatology.
• Microbiota and the brain: mechanisms of the gut–brain axis (Cryan, J. F., & Dinan, T. G., 2015). Nature Reviews Neuroscience.
• Intestinal permeability and the pathophysiology of leaky gut (Fasano, A., 2012). Annals of the New York Academy of Sciences.
• Metabolic endotoxemia initiates obesity and insulin resistance (Cani, P. D., et al., 2007). Diabetes.
• The estrobolome and estrogen metabolism in health and disease (Plottel, C. S., & Blaser, M. J., 2011). Gut Microbes.
• Gut microbiota, beta-glucuronidase, and estrogen metabolism (Flores, R. et al., 2012). Journal of Translational Medicine.
• Endometriosis, inflammation, and the microbiome (Taylor, H. S., et al., 2020). Frontiers in Endocrinology.
• Estrogen metabolism pathways and clinical implications (Yager, J. D., & Davidson, N. E., 2006). Nature Reviews Cancer.
• Selenium supplementation and thyroid autoimmunity (Gärtner, R. et al., 2002). The Journal of Clinical Endocrinology & Metabolism.
• Hashimoto’s thyroiditis: pathophysiology and management (Caturegli, P., De Remigis, A., & Rose, N. R., 2014). Endocrine Reviews.
• Vitamin D and risk of disease: meta-analyses and randomized trials (Pilz, S., Trummer, C., Pandis, M., et al., 2019). Nature Reviews Endocrinology.
• Global prevalence of vitamin D deficiency and health implications (Mitchell, E. et al., 2022). Nutrients.
• Vitamin K2 in bone and cardiovascular health (Beulens, J. W. J., et al., 2013). Advances in Nutrition.
• Iodine nutrition and thyroid disorders (Zimmermann, M. B., 2003). The Journal of Clinical Endocrinology & Metabolism.
• Vagus nerve regulation of inflammation (Tracey, K. J., 2002). Nature Immunology.
• Diindolylmethane: mechanisms of estrogen metabolism modulation and clinical applications (Bradlow, H. L., 2019). Phytotherapy Research.
• The estrogen metabolite ratio and breast tissue risk (Kabat, G. C., et al., 2006). Cancer Epidemiology, Biomarkers & Prevention.
• Sulforaphane, Nrf2 activation, and phase II detoxification (Singh, A. et al., 2011). Oncogene.
• Shilajit and testosterone in healthy males: RCT (Pandit, R. et al., 2016). Andrologia.
• Akkermansia muciniphila and metabolic health: evidence and mechanisms (Everard, A., & Cani, P. D., 2013). Nature Reviews Microbiology.
• Zinc carnosine and mucosal healing (Ueda, Y. et al., 2007). Alimentary Pharmacology & Therapeutics.
• The estrobolome and estrogen metabolism (Kwa, M. et al., 2018). Frontiers in Endocrinology.
• Clinical observations and resources:
• ChiroMed El Paso (Jimenez, A., n.d.-a).
• Professional profile and practice updates (Jimenez, A., n.d.-b).

SEO tags: gut health, dysbiosis, intestinal permeability, LPS, SCFAs, estrobolome, beta-glucuronidase, estrogen metabolism, DIM, I3C, calcium D-glucarate, vitamin D3, vitamin K2, vitamin A, iodine, selenium, Hashimoto’s, thyroid conversion, Akkermansia muciniphila, shilajit, free testosterone, HRT pellets, integrative chiropractic care, vagal tone, HRV, functional medicine, microbiome sequencing, metabolomics, NF-κB, TLR4, COMT, Nrf2